These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19168026)

  • 1. The role of the mitochondrial permeability transition pore in heart disease.
    Halestrap AP; Pasdois P
    Biochim Biophys Acta; 2009 Nov; 1787(11):1402-15. PubMed ID: 19168026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection.
    Halestrap AP
    Biochem Soc Trans; 2010 Aug; 38(4):841-60. PubMed ID: 20658967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the mitochondrial permeability transition pore?
    Halestrap AP
    J Mol Cell Cardiol; 2009 Jun; 46(6):821-31. PubMed ID: 19265700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition.
    Leung AW; Varanyuwatana P; Halestrap AP
    J Biol Chem; 2008 Sep; 283(39):26312-23. PubMed ID: 18667415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.
    Clarke SJ; McStay GP; Halestrap AP
    J Biol Chem; 2002 Sep; 277(38):34793-9. PubMed ID: 12095984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore.
    Leung AW; Halestrap AP
    Biochim Biophys Acta; 2008; 1777(7-8):946-52. PubMed ID: 18407825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases.
    Javadov S; Karmazyn M; Escobales N
    J Pharmacol Exp Ther; 2009 Sep; 330(3):670-8. PubMed ID: 19509316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.
    Halestrap AP; Richardson AP
    J Mol Cell Cardiol; 2015 Jan; 78():129-41. PubMed ID: 25179911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death.
    Halestrap AP; Brenner C
    Curr Med Chem; 2003 Aug; 10(16):1507-25. PubMed ID: 12871123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart.
    Halestrap AP; Kerr PM; Javadov S; Woodfield KY
    Biochim Biophys Acta; 1998 Aug; 1366(1-2):79-94. PubMed ID: 9714750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The permeability transition pore complex: another view.
    Halestrap AP; McStay GP; Clarke SJ
    Biochimie; 2002; 84(2-3):153-66. PubMed ID: 12022946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion.
    Schriewer JM; Peek CB; Bass J; Schumacker PT
    J Am Heart Assoc; 2013 Apr; 2(2):e000159. PubMed ID: 23598272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not all mitochondrial carrier proteins support permeability transition pore formation: no involvement of uncoupling protein 1.
    Crichton PG; Parker N; Vidal-Puig AJ; Brand MD
    Biosci Rep; 2009 Dec; 30(3):187-92. PubMed ID: 19622065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore.
    Lim SY; Davidson SM; Mocanu MM; Yellon DM; Smith CC
    Cardiovasc Drugs Ther; 2007 Dec; 21(6):467-9. PubMed ID: 17965927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To involvement the conformation of the adenine nucleotide translocase in opening the Tl(+)-induced permeability transition pore in Ca(2+)-loaded rat liver mitochondria.
    Korotkov SM; Konovalova SA; Brailovskaya IV; Saris NE
    Toxicol In Vitro; 2016 Apr; 32():320-32. PubMed ID: 26835787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the mitochondrial permeability transition pore for drug discovery: Challenges and opportunities.
    Boyenle ID; Oyedele AK; Ogunlana AT; Adeyemo AF; Oyelere FS; Akinola OB; Adelusi TI; Ehigie LO; Ehigie AF
    Mitochondrion; 2022 Mar; 63():57-71. PubMed ID: 35077882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice.
    Elrod JW; Wong R; Mishra S; Vagnozzi RJ; Sakthievel B; Goonasekera SA; Karch J; Gabel S; Farber J; Force T; Brown JH; Murphy E; Molkentin JD
    J Clin Invest; 2010 Oct; 120(10):3680-7. PubMed ID: 20890047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.
    Lim SY; Davidson SM; Hausenloy DJ; Yellon DM
    Cardiovasc Res; 2007 Aug; 75(3):530-5. PubMed ID: 17512507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection.
    Bell RM; Kunuthur SP; Hendry C; Bruce-Hickman D; Davidson S; Yellon DM
    Basic Res Cardiol; 2013 Mar; 108(2):331. PubMed ID: 23361433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury.
    Kim SY; Shim MS; Kim KY; Weinreb RN; Wheeler LA; Ju WK
    Cell Death Dis; 2014 Mar; 5(3):e1105. PubMed ID: 24603333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.